ELYSE SPENCER: Open Payments
NPI 1740243096 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,797 in 80 payments from 17 companies in 2025. Trend: 2023 $1,366 · 2024 $1,359 · 2025 $1,797
Food & beverage: $1,712Education: $85
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $469 |
| Janssen Biotech, Inc. | 9 | $167 |
| Galderma Laboratories, L.P. | 11 | $144 |
| ABBVIE INC. | 8 | $139 |
| Incyte Corporation | 5 | $109 |
| PFIZER INC. | 5 | $109 |
| GENZYME CORPORATION | 4 | $101 |
| LEO Pharma Inc. | 4 | $98 |
| UCB, Inc. | 4 | $80 |
| Botanix SB Inc | 3 | $73 |
Products named: Winlevi, TREMFYA, NEMLUVIO, OPZELURA, DUPIXENT, ILUMYA, Bimzelx, ADBRY.
Industry payments across TX — which companies pay providers there.
